Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
NeuroSearch A/S |
---|---|
Information provided by: | NeuroSearch A/S |
ClinicalTrials.gov Identifier: | NCT00481104 |
Purpose of the study is to evaluate the long term safety of tesofensine in obese patients
Condition | Intervention | Phase |
---|---|---|
Obesity |
Drug: Tesofensine |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Open Label, Uncontrolled, Single Group Assignment, Safety Study |
Official Title: | Evaluation of Long Term Safety of Tesofensine in Patients With Obesity |
Estimated Enrollment: | 150 |
Study Start Date: | May 2007 |
Estimated Study Completion Date: | November 2008 |
Estimated Primary Completion Date: | November 2008 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Patients who have completed their participation in TIPO-1
Exclusion Criteria:
Denmark, Frederiksberg | |
Faculty of Life Sciences, University of Copenhagen | |
Copenhagen, Frederiksberg, Denmark, 1958 |
Principal Investigator: | Arne V Astrup, Professor, MD | Faculty of Life Science, University of Copenhagen, Denmark |
Study ID Numbers: | NS2330-004 |
Study First Received: | May 31, 2007 |
Last Updated: | March 3, 2008 |
ClinicalTrials.gov Identifier: | NCT00481104 |
Health Authority: | Denmark: Danish Medicines Agency |
Obesity |
Body Weight Signs and Symptoms Obesity |
Nutrition Disorders Overweight Overnutrition |